Test
EZ-Tn5™ Transposase is a hyperactive Tn5 transposase for random insertion of an EZ-Tn5 Transposon into any cloned DNA in vitro or for preparing an EZ-Tn5 Transposome for random insertion of a EZ-Tn5 Transposon into the genomic DNA of living bacteria.
For the BD FACSVia system: The BD CS&T Beads are intended for use on the BD FACSVia flow cytometer system with BD FACSVia clinical software for the verification of optical and fluidic performance and to adjust compensation on the flow cytometer. For the BD FACSLyric flow cytometer: BD CS&T beads, in conjunction with BD FACSuite Clinical software, provide a standardized method for the quality control of optics, electronics, and fluidics, and for adjusting detector voltages and fluorescence compensation on the BD FACSLyric flow cytometer.
Cell Biolabs' QuickTiter™ MuLV Core Antigen ELISA Kit measures the p30 core antigen of MuLV with sensitivity as low as 300 pg/mL. The kit provides sufficient reagents for 96 assays including standards and unknown samples.
The GTxResolve Premier SEC 1000Å, 3 μm, 4.6 x 300 mm Column is manufactured with low adsorption MaxPeak HPS hardware and novel bridged ethylene HO-PEO particles to support high recovery analyses of 200 to 800Å diameter GTx drugs, such as mRNA, LNPs, and viral vectors. This column technology provides long column lifetimes, low secondary interactions, and improved MALS sensitivity. Facilitate the development of platform multiattribute SEC assays for mRNA integrity and LNP formulations analyses as well as improved detection of ejected transgenes and aggregates related to viral vectors
*Inquiry about volume discounts on orders of 2+
Hooke Kits™ for EAE Induction in C57BL/6 Mice. Emulsion supplied in pre-filled syringes, ready to use. Consistently induces EAE in female C57BL/6 mice EAE will develop in 90-100% of mice. Disease onset is 9 to 14 days after immunization. Mean maximum score will be 3.0 to 3.5. Each lot is tested and individually adjusted to ensure consistent disease induction. On Day 0, MOG35-55/CFA or MOG1-125/CFA emulsion and pertussis toxin are injected. On Day 1, a second dose of pertussis toxin is injected.roperly prepared emulsions are critical for reliable induction of many autoimmune disease models. Our emulsions are carefully made and pre-filled into syringes, ready to use, to reduce time needed to set up experiments.Lot-to-lot reagent variations can cause dramatic changes in severity of induced autoimmune disease.
WuXi TIDES N-Fmoc-O-Methyl-L-Homoserine, 173212-86-7 | N-(((9H-fluoren-9-yl)methoxy)carbonyl)-O-methyl-L-homoserine | COCC[C@H](NC(OCC1C2=CC=CC=C2C3=CC=CC=C31)=O)C(O)=O | M.F. C20H21NO5, M.W. 355.39
WuXi TIDES Fmoc-D-Aad-OH, 218457-73-9 | (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)hexanedioic acid | O=C(O)CCC[C@H](C(O)=O)NC(OCC1C2=CC=CC=C2C3=CC=CC=C31)=O | M.F. C21H21NO6, M.W. 383.4
WuXi TIDES Fmoc-L-Cys(Boc-aminopropyl)-OH, 173963-91-2 | N-(((9H-fluoren-9-yl)methoxy)carbonyl)-S-(3-((tert-butoxycarbonyl)amino)propyl)-L-cysteine | CC(C)(OC(NCCCSC[C@H](NC(OCC1C2=CC=CC=C2C3=CC=CC=C31)=O)C(O)=O)=O)C | M.F. C26H32N2O6S, M.W. 500.61
WuXi TIDES (2R)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2-phenylpropanoic acid, 881920-86-1 | 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-phenylpropanoic acid | CC(NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)(C(O)=O)C4=CC=CC=C4 | M.F. C24H21NO4, M.W. 387.44
WuXi TIDES Fmoc-(2S,4S)-4-amino-1-benzoyl-pyrrolidine-2-carboxylic acid, 204321-85-7 | (2S,4S)-4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-1-benzoylpyrrolidine-2-carboxylic acid | O=C(N1C[C@@H](NC(OCC2C3=CC=CC=C3C4=CC=CC=C42)=O)C[C@H]1C(O)=O)C5=CC=CC=C5 | M.F. C27H24N2O5, M.W. 456.5
WuXi TIDES Fmoc-L-Oic-OH, 130309-37-4 | (2S,3aS,7aS)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)octahydro-1H-indole-2-carboxylic acid | C1CC[C@H]2[C@@H](C1)C[C@@H](C(=O)O)N2C(=O)OCC3C4=CC=CC=C4C5=CC=CC=C53 | M.F. C24H25NO4, M.W. 391.47
WuXi TIDES Fmoc-(S)-3-Amino-3-(3,5-dimethoxy-phenyl)-propionicacid, 501015-38-9 | (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,5-dimethoxyphenyl)propanoic acid | COC1=CC(OC)=CC([C@@H](NC(OCC2C3=CC=CC=C3C4=CC=CC=C42)=O)CC(O)=O)=C1 | M.F. C26H25NO6, M.W. 447.49
WuXi TIDES Fmoc-D-Thr(HPO3Bzl)-OH, 937171-63-6 | N-(((9H-fluoren-9-yl)methoxy)carbonyl)-O-((benzyloxy)(hydroxy)phosphoryl)-D-threonine | C[C@H](OP(O)(OCC1=CC=CC=C1)=O)[C@@H](NC(OCC2C3=CC=CC=C3C4=CC=CC=C42)=O)C(O)=O | M.F. C26H26NO8P, M.W. 511.47
WuXi TIDES (S)-2-(Fmoc-amino)-5-phenyl-4-pentenoic acid, 215190-24-2 | (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-phenylpent-4-enoic acid | O=C(O)[C@@H](NC(OCC1C2=CC=CC=C2C3=CC=CC=C31)=O)CC=CC4=CC=CC=C4 | M.F. C26H23NO4, M.W. 413.47
WuXi TIDES Fmoc-L-Gln(Trt)-OPfp, 132388-65-9 | perfluorophenyl N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N5-trityl-L-glutaminate | O=C(OC1=C(F)C(F)=C(F)C(F)=C1F)[C@@H](NC(OCC2C3=CC=CC=C3C4=CC=CC=C42)=O)CCC(NC(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)=O | M.F. C45H33F5N2O5, M.W. 776.76